Pomalidomide-PEG3-Alkyne

Background Introduction

Pomalidomide-PEG3-Alkyne is a versatile E3 ligase ligand-linker conjugate, featuring pomalidomide—a cereblon (CRBN) binding ligand—connected via a triethylene glycol (PEG3) spacer to an alkyne functional group. This chemically defined, modular structure enables its widespread use in targeted protein degradation research, particularly in the development of PROTAC (Proteolysis Targeting Chimera) molecules and related bifunctional degraders.

Mechanism

The mechanism of Pomalidomide-PEG3-Alkyne involves its ability to recruit the E3 ubiquitin ligase cereblon (CRBN) through the pomalidomide moiety. The PEG3 linker imparts optimal spatial flexibility and solubility, while the terminal alkyne group enables efficient 'click' chemistry (e.g., copper-catalyzed azide-alkyne cycloaddition, CuAAC) for conjugation to diverse ligands or small molecules. Once incorporated into a PROTAC, the molecule brings a target protein into proximity with the CRBN E3 ligase, facilitating its ubiquitination and subsequent degradation by the proteasome.

Applications

Pomalidomide-PEG3-Alkyne is widely applied in chemical biology and drug discovery for the synthesis of PROTACs targeting a diverse range of proteins. The terminal alkyne allows facile attachment to protein-binding ligands via click chemistry, enabling the rapid generation of customized bifunctional degraders. Additionally, this conjugate serves as a key intermediate for the development of molecular glues, targeted protein degradation probes, and chemical proteomics tools. It supports research in oncology, neurodegenerative diseases, and other therapeutic areas where controlled protein knockdown is desired.

The E3 Ligase Ligand-Linker Conjugate, Pomalidomide-PEG3-Alkyne, plays a pivotal role in the development of PROTACs by facilitating targeted protein degradation. This conjugate is characterized by its ability to connect a ligand for E3 ubiquitin ligase to a target protein ligand through a versatile linker, enhancing the specificity and efficacy of protein degradation.

Linker: The linker in this molecule is a PEG3 chain, providing moderate length and flexibility. This polyethylene glycol-based linker is non-cleavable, ensuring stability in cellular environments while maintaining the necessary spatial arrangement for optimal interaction between the ligands.

Ligand: The ligand component of this molecule is Pomalidomide, a thalidomide derivative known for its high affinity for the CRBN E3 ligase. Its structural characteristics include a glutarimide ring, which facilitates binding to the E3 ligase, thereby enhancing the degradation of target proteins.

Reactive Site: The reactive site of this molecule is the terminal alkyne group. This site is designed to couple with azide-functionalized target protein ligands through a copper-catalyzed azide-alkyne cycloaddition (CuAAC), commonly known as a "click" reaction, ensuring efficient and selective conjugation.

Recommended Target Protein Ligand: The recommended warhead for this conjugate is an azide-functionalized ligand. This warhead allows for a robust and bioorthogonal "click" reaction with the alkyne group, facilitating the creation of a stable and effective ternary complex. This approach is advantageous in experimental studies seeking to elucidate protein function and validate therapeutic targets through selective protein degradation.